BioNova Pharma Revenue and Competitors
Estimated Revenue & Valuation
- BioNova Pharma's estimated annual revenue is currently $3.4M per year.
- BioNova Pharma's estimated revenue per employee is $201,000
Employee Data
- BioNova Pharma has 17 Employees.
- BioNova Pharma grew their employee count by 6% last year.
BioNova Pharma's People
Name | Title | Email/Phone |
---|
BioNova Pharma Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $46.2M | 230 | 5% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $24.5M | 122 | 3% | N/A | N/A |
#5 | $52.9M | 263 | 13% | N/A | N/A |
#6 | $24.7M | 123 | 13% | N/A | N/A |
#7 | $1.8M | 18 | 0% | $114.3M | N/A |
#8 | $7.2M | 36 | -20% | N/A | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $7.6M | 39 | -13% | $123.9M | N/A |
What Is BioNova Pharma?
BioNova Pharmaceuticals Ltd is an innovative biotech company engaged primarily in the discovery, development and commercialization of breakthrough therapies for the treatment of diseases with high unmet medical need, with a focus on the Greater China market Our talent, scientific knowledge and research capabilities help us accelerate drug development in China and bring innovative medicines to the Chinese patients
keywords:N/AN/A
Total Funding
17
Number of Employees
$3.4M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
BioNova Pharma News
Bionova Scientific is a portfolio company of Great Point Partners, a Greenwich, CT-based private investment firm focused exclusively on the...
In 2019, Asahi Kasei Group agreed to acquire Danish pharma company Veloxis Pharmaceuticals through its Danish subsidiary Asahi Kasei Pharma...
Now, the British pharma giant has gotten a taste of what that rebound will look likeeven though CEO Emma Walmsley still warns of speed bumps ahead. Shingrix...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.1M | 17 | -23% | N/A |
#2 | $1.5M | 17 | N/A | N/A |
#3 | $1.5M | 17 | N/A | N/A |
#4 | $1.5M | 17 | N/A | N/A |
#5 | $1.5M | 17 | N/A | N/A |